In 2004, Olive et al. reported that p53R172H/− (mouse R172H refers to human R175H) and p53R270H/− (mouse R270H refers to human R273H) mice developed novel tumors compared to p53−/− mice, including a variety of carcinomas and more frequent endothelial tumors [15]. Here, TP53 is linked to carcinoma.